Olanzapine for the Prevention of Postoperative Nausea and Vomiting

Clinical trial NCT04718727 · COMPLETED

Trial details

NCT number: NCT04718727
Sponsor: Amani Hassan Abdel-Wahab
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Postoperative Nausea

Start date: 2021-03-15
Primary completion: 2023-02-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.